Intellia Therapeutics, Inc.
DE ˙ DB ˙ US45826J1051
12,04 € ↓ -0,96 (-7,38%)
2026-06-05
CENA AKCJI
SecurityDE:38I / Intellia Therapeutics, Inc.
InstitutionMorgan Stanley
Latest Disclosed Ownership2,081,397 shares
Latest Disclosed Value $ 26,683,520
Morgan Stanley reports 10.59% decrease in ownership of 38I / Intellia Therapeutics, Inc.

On May 15, 2026 - Morgan Stanley filed a 13F-HR form disclosing ownership of 2,081,397 shares of Intellia Therapeutics, Inc. (DE:38I) valued at $22,999,437 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on May 27, 2026 disclosing 2,327,852 shares of Intellia Therapeutics, Inc.. This represents a change in shares of -10.59% during the quarter. The current value of the position is $25,060,020 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 2,081,397 -246,455 -10.59 26,684 27.51 0.0016
2026-05-27 2025-12-31 13F/A-1 INTELLIA THERAPEUTICS COM 45826J105 2,327,852 -3,694,724 -61.35 20,927 -79.88 0.0012
2026-02-13 2025-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 2,327,852 -3,694,724 20,927
2026-05-27 2025-09-30 13F/A-1 INTELLIA THERAPEUTICS COM 45826J105 6,022,576 1,905,715 46.29 104,010 169.34 0.0063
2025-11-14 2025-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 6,022,576 1,905,715 104,010 0.0063
2025-08-15 2025-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 4,116,861 315,166 8.29 38,616 42.86 0.0025
2025-05-15 2025-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 3,801,695 -12,851 -0.34 27,030 -39.23 0.0019
2025-05-15 2024-12-31 13F/A-1 INTELLIA THERAPEUTICS COM 45826J105 3,814,546 1,238,512 48.08 44,478 -15.98 0.0031
2025-02-14 2024-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 3,814,546 1,238,512 44,478 0.0031
2025-05-14 2024-09-30 13F/A-2 INTELLIA THERAPEUTICS COM 45826J105 2,576,034 238,325 10.19 52,938 1.19 0.0038
2025-02-14 2024-09-30 13F/A-1 INTELLIA THERAPEUTICS COM 45826J105 2,576,034 238,325 52,938 0.0038
2024-11-14 2024-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 2,576,034 238,325 52,938 0.0038
2025-05-14 2024-06-30 13F/A-2 INTELLIA THERAPEUTICS COM 45826J105 2,337,709 -307,142 -11.61 52,318 -28.10 0.0040
2024-10-17 2024-06-30 13F/A-1 INTELLIA THERAPEUTICS COM 45826J105 2,337,709 -307,142 52,318 0.0040
2024-08-14 2024-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 2,337,709 -307,142 52,318 0.0040
2024-10-17 2024-03-31 13F/A-2 INTELLIA THERAPEUTICS COM 45826J105 2,644,851 99,829 3.92 72,760 -6.23 0.0058
2024-08-16 2024-03-31 13F/A-1 INTELLIA THERAPEUTICS COM 45826J105 2,644,851 99,829 72,760 0.0007
2024-05-15 2024-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 2,644,851 99,829 72,760 0.0058
2024-08-16 2023-12-31 13F/A-1 INTELLIA THERAPEUTICS COM 45826J105 2,545,022 -545,919 -17.66 77,598 -20.60 0.0068
2024-02-13 2023-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 2,545,022 -545,919 77,598 0.0068
2023-11-15 2023-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 3,090,941 241,734 8.48 97,736 -15.88 0.0099
2023-08-14 2023-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 2,849,207 193,724 7.30 116,191 17.40 0.0115
2023-05-15 2023-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 2,655,483 137,333 5.45 98,970 12.65 0.0106
2023-02-14 2022-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 2,518,150 987,599 64.53 87,858 2.58 0.0100
2022-11-14 2022-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 1,530,551 294,357 23.81 85,650 33.86 0.0117
2022-10-27 2022-06-30 13F/A-1 INTELLIA THERAPEUTICS COM 45826J105 1,236,194 -58,805 -4.54 63,984 -32.01 0.0083
2022-08-15 2022-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 1,236,194 -58,805 63,984 0.0083
2022-10-27 2022-03-31 13F/A-1 INTELLIA THERAPEUTICS COM 45826J105 1,294,999 -228,254 -14.98 94,109 -47.75 0.0127
2022-05-13 2022-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 1,294,999 -228,254 94,109 0.0127
2022-02-14 2021-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 1,523,253 377,214 32.91 180,110 17.15 0.0222
2021-11-15 2021-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 1,146,039 448,316 64.25 153,742 36.09 0.0207
2021-08-23 2021-06-30 13F/A-1 INTELLIA THERAPEUTICS COM 45826J105 697,723 192,393 38.07 112,968 178.56 0.0149
2021-08-16 2021-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 697,723 192,393 112,968 0.0031
2021-05-17 2021-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 505,330 -671,125 -57.05 40,554 -36.63 0.0060
2021-02-16 2020-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 1,176,455 -10,378 -0.87 63,998 171.24 0.0099
2020-11-13 2020-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 1,186,833 406,842 52.16 23,595 43.91 0.0046
2020-08-14 2020-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 779,991 131,139 20.21 16,396 106.63 0.0036
2020-05-26 2020-03-31 13F/A-1 INTELLIA THERAPEUTICS COM 45826J105 648,852 -303,414 -31.86 7,935 -43.20 0.0022
2020-05-15 2020-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 648,852 -303,414 7,935 609.5734
2020-02-14 2019-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 952,266 29,879 3.24 13,970 13.45 0.0032
2019-11-14 2019-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 922,387 33,126 3.73 12,314 -15.41 0.0033
2019-08-14 2019-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 889,261 -1,075,202 -54.73 14,557 -56.61 0.0039
2019-05-15 2019-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 1,964,463 -267,783 -12.00 33,552 10.11 0.0095
2019-02-14 2018-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 2,232,246 262,189 13.31 30,470 -45.96 0.0091
2019-04-23 2018-09-30 13F/A-2 INTELLIA THERAPEUTICS COM 45826J105 1,970,057 -264,242 -11.83 56,384 -7.76 0.0141
2018-11-20 2018-09-30 13F/A-1 INTELLIA THERAPEUTICS COM 45826J105 1,970,057 0 56,384 0.0141
2018-11-14 2018-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 1,970,057 -264,242 56,384
2019-04-23 2018-06-30 13F/A-1 INTELLIA THERAPEUTICS COM 45826J105 2,234,299 324,280 16.98 61,129 51.75 0.0165
2018-08-14 2018-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 2,234,299 324,280 61,129
2019-04-23 2018-03-31 13F/A-1 INTELLIA THERAPEUTICS COM 45826J105 1,910,019 1,581,092 480.68 40,282 537.17 0.0112
2018-05-14 2018-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 1,910,019 1,581,092 40,282
2019-04-23 2017-12-31 13F/A-1 INTELLIA THERAPEUTICS COM 45826J105 328,927 39,559 13.67 6,322 -12.07 0.0017
2018-02-14 2017-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 328,927 39,559 6,322
2017-11-14 2017-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 289,368 43,959 17.91 7,190 83.14 0.0022
2017-08-11 2017-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 245,409 33,884 16.02 3,926 31.74 0.0012
2017-05-22 2017-03-31 13F/A-1 INTELLIA THERAPEUTICS COM 45826J105 211,525 -33,955 -13.83 2,980 -7.40 0.0009
2017-05-12 2017-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 211,525 2,980
2017-02-22 2016-12-31 13F/A-1 INTELLIA THERAPEUTICS COM 45826J105 245,480 -37,346 -13.20 3,218 -33.15 0.0011
2017-02-13 2016-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 245,480 3,218
2016-11-10 2016-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 282,826 -18,532 -6.15 4,814 -25.18 0.0016
2016-08-12 2016-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 301,358 301,358 6,434 0.0023
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.